About Us

The Fireflies Tour

Each year the Fireflies Tour traverses 1000km across the French Alps, from Geneva to Cannes, to help raise money for Leuka.

The Fireflies Tour was established in 2001 by Sandy Watson Scott (then Head of TV, M&C Saatchi) in recognition of relatives and friends’ Battles with Cancer. The five cofounders: Jake Scott, Adrian Moat, Nick Livesey (Directors at RSA Films), Tim Page (Head of TV at Y&R) and Chris Haworth (Ski Instructor) set out to cycle 1,000 km, 18 mountains in just 8 days from Lake Evian across the Alps to Cannes, arriving during the Cannes Lions Advertising Festival.

Inspired by the courage it takes to fight Cancer the riders annually tackle the most gruelling climbs of Le Tour de France. Their motto is simple: “for those who suffer we ride”. The Fireflies are committed to raising money for Leuka, a charity formed to support Research & Treatment of Leukaemia at the Hammersmith Hospital, London, renowned as a world leader in the treatment of cancers of the blood.

Each year new amateur cyclists from the ranks of the advertising and film world have taken up the challenge. Thanks to industry Sponsors, to date from 2001-09, the Fireflies have raised an incredible £800,000 in aid of Leuka. 1 in 3 of us will be diagnosed with some type of Cancer in our lifetime. It is believed that Leukaemia is the model of all Cancers and achieving a greater understanding of this disease will help in the fight against All other forms of Cancer.

2010 is the 10th anniversary Tour and to mark this milestone, the Fireflies are aiming to Smash their £1 million target.

Find out how you can sponsor us email Laine Lindsay Law at RSA films or for more information contact us here.

Leuka

Leuka raises funds to support life-saving research into the causes and treatment of leukaemia and other blood disorders. Its goal is simple: to create a better future for patients both here in the UK and abroad.

Leukaemia is not common, but for those diagnosed with the disease, it is very real and frightening. Researchers at the hospital continue to explore new and better methods of controlling leukaemia and other haematological malignancies, and to ensure that any advances in treatment reach the bedside as quickly as possible.

To find out more about what Leuka do visit their website www.leuka.org.uk.